AVALO THERAPEUTICS INC - COM NEW (AVTX)

CUSIP: 05338F207

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM NEW
Total 13F shares
1,339,653
Share change
-1,086,518
Total reported value
$158,937
Price per share
$0.12
Number of holders
26
Value change
-$574,491
Number of buys
14
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 05338F207?
CUSIP 05338F207 identifies AVTX - AVALO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVALO THERAPEUTICS INC - COM NEW (AVTX) as of Q3 2023

As of 30 Sep 2023, AVALO THERAPEUTICS INC - COM NEW (AVTX) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,339,653 shares. The largest 10 holders included ACADIAN ASSET MANAGEMENT LLC, Virtu Financial LLC, Baader Bank Aktiengesellschaft, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, Banque Cantonale Vaudoise, Tower Research Capital LLC (TRC), Vanguard Personalized Indexing Management, LLC, and LEVEL FOUR ADVISORY SERVICES, LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.